A Greek Validation Study of the Multiple Sclerosis Work Difficulties Questionnaire-23.

MSWDQ-23 employment multiple sclerosis patient-reported outcome validation

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
15 Jul 2021
Historique:
received: 25 05 2021
revised: 02 07 2021
accepted: 13 07 2021
entrez: 6 8 2021
pubmed: 7 8 2021
medline: 7 8 2021
Statut: epublish

Résumé

The Multiple Sclerosis Work Difficulties Questionnaire-23 (MSWDQ-23) is a self-report instrument developed to assess barriers faced by People with Multiple Sclerosis (PwMS) in the workplace. The aim of this study was to explore the psychometric properties of the Greek version of the MSWDQ-23. The study sample consisted of 196 PwMS, all currently working in part- or full-time jobs. Participants underwent clinical examination and cognitive screening with the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and completed self-report measures of fatigue, psychological functioning, and quality of life, along with the MSWDQ-23 questionnaire. Confirmatory Factor Analysis (CFA) was performed, and goodness-of-fit measures were used to evaluate construct validity. Convergent validity was checked by correlating MSWDQ-23 scores with study measures. Cronbach's alpha value was produced to assess internal consistency. CFA yielded a model with a fair fit confirming the three-factor structure of the instrument. Higher work difficulties were associated with higher Expanded Disability Status Scale (EDSS) scores, poorer cognitive function, more fatigue, stress, anxiety, and depression, and poorer health status, supporting the convergent validity of MSWDQ-23. Internal consistency (Cronbach's alpha = 0.94) and test-retest reliability (ICC = 0.996, 95%, CI = 0.990-0.998) were excellent. The Greek MSWDQ-23 can be considered a valid patient-reported outcome measure and can be used in interventions aiming to improve the vocational status of PwMS.

Identifiants

pubmed: 34356274
pii: healthcare9070897
doi: 10.3390/healthcare9070897
pmc: PMC8306802
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Clin Neurol Neurosurg. 2015 Nov;138:20-4
pubmed: 26264722
Mult Scler. 2019 Jan;25(1):104-112
pubmed: 29143553
Arch Clin Neuropsychol. 2013 Feb;28(1):52-64
pubmed: 23179043
Mult Scler J Exp Transl Clin. 2020 Jan 27;6(1):2055217320902481
pubmed: 32064116
Brain. 2001 May;124(Pt 5):962-73
pubmed: 11335698
Mult Scler. 2013 Aug;19(9):1122-7
pubmed: 23897894
J Int Neuropsychol Soc. 2015 Feb;21(2):156-68
pubmed: 25727930
Disabil Rehabil. 2016;38(10):936-44
pubmed: 26213244
Qual Life Res. 2006 Mar;15(2):259-71
pubmed: 16468081
Mult Scler. 2017 Sep;23(10):1385-1393
pubmed: 27885064
Mult Scler. 2017 Jul;23(8):1123-1136
pubmed: 28273775
Mult Scler Relat Disord. 2016 Sep;9:68-72
pubmed: 27645348
Mult Scler. 2013 Nov;19(13):1792-9
pubmed: 23635910
Nat Rev Dis Primers. 2018 Nov 8;4(1):43
pubmed: 30410033
Disabil Rehabil. 2014;36(8):635-41
pubmed: 23786346
Disabil Rehabil. 2021 Jun;43(13):1924-1933
pubmed: 31702954
Int J Rehabil Res. 2014 Sep;37(3):271-6
pubmed: 24557490
Value Health. 2008 Dec;11(7):1162-9
pubmed: 18489492
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Mult Scler. 2010 May;16(5):581-7
pubmed: 20194578
Mult Scler. 2017 May;23(6):848-854
pubmed: 27527906
Value Health. 2012 Dec;15(8):1029-35
pubmed: 23244804
Curr Neurol Neurosci Rep. 2020 May 26;20(7):24
pubmed: 32458308
Front Neurol. 2020 Mar 06;11:147
pubmed: 32210905
Arch Phys Med Rehabil. 2004 Feb;85(2):201-9
pubmed: 14966703
Mult Scler. 2012 Jun;18(6):871-80
pubmed: 22146603
Mult Scler. 2012 Jun;18(6):891-8
pubmed: 22190573
Neurology. 2013 Jun 11;80(24):2186-93
pubmed: 23667062
Disabil Rehabil. 2019 Oct;41(21):2556-2562
pubmed: 29741962
Mult Scler Relat Disord. 2020 Nov;46:102559
pubmed: 33035965
Mult Scler Relat Disord. 2018 May;22:115-119
pubmed: 29656271
Front Neurol. 2020 Sep 29;11:1012
pubmed: 33132996

Auteurs

Christos Bakirtzis (C)

Multiple Sclerosis Center, Second Department of Neurology, Aristotle University of Thessaloniki, GR 54124 Thessaloniki, Greece.

Artemios Artemiadis (A)

Faculty of Medicine, University of Cyprus, Nicosia CY 2029, Cyprus.

Elli Nteli (E)

Multiple Sclerosis Center, Second Department of Neurology, Aristotle University of Thessaloniki, GR 54124 Thessaloniki, Greece.

Marina Kleopatra Boziki (MK)

Multiple Sclerosis Center, Second Department of Neurology, Aristotle University of Thessaloniki, GR 54124 Thessaloniki, Greece.

Maria-Valeria Karakasi (MV)

Third University Department of Psychiatry, AHEPA University General Hospital, GR 54124 Thessaloniki, Greece.

Cynthia Honan (C)

School of Psychological Sciences, College of Health and Medicine, University of Tasmania, TAS 7250 Launceston, Australia.

Lambros Messinis (L)

Neuropsychology Section, University Hospital of Patras, GR 26504 Patras, Greece.

Grigorios Nasios (G)

Department of Speech and Language Therapy, University of Ioannina, GR 45110 Ioannina, Greece.

Efthimios Dardiotis (E)

Department of Neurology, University of Thessaly, GR 41500 Larisa, Greece.

Nikolaos Grigoriadis (N)

Multiple Sclerosis Center, Second Department of Neurology, Aristotle University of Thessaloniki, GR 54124 Thessaloniki, Greece.

Classifications MeSH